Biology Reference
In-Depth Information
45. Frossard N, Barnes PJ. Effect of tachykinins in small human airways. Neuropeptides
1991;19:157-61.
46. Fuller RW, Maxwell DL, Dixon CM, McGregor GP, Barnes VF, Bloom SR and Barnes
PJ, et al. Effect of substance P on cardiovascular and respiratory function in subjects.
J Appl Physiol 1987;62:1473-79.
47. Evans TW, Dixon CM, Clarke B, Conradson T-B, Barnes PJ. Comparison of neurokinin A
and substance P on cardiovascular and airway function in man. Br J Clin Pharmacol
1988;25:273-75.
48. Joos G, Pauwels R, Van Der Straeten M. The effect of inhaled substance P and neurokinin A
on the airways of normal and asthmatic subjects. Thorax 1987;42:779-83.
49. Cheung D, Bel EH, Den Hartigh J, Dijkman JH, Sterk PJ. The effect of an inhaled neu-
tral endopeptidase inhibitor, thiorphan, on airway responses to neurokinin A in normal
humans
in vivo
. Am Rev Respir Dis 1992;145:1275-80.
50. Lundberg JM, Saria A. Polypeptide-containing neurons in airway smooth muscle. Annu
Rev Physiol 1987;49:557-72.
51. Lundberg JM, Martling C-R, Saria A. Substance P and capsaicin-induced contraction of
human bronchi. Acta Physiol Scand 1983;119:49-53.
52. Honda I, Kohrogi M, Yamaguchi T, Ando M, Araki S. Enkephalinase inhibitor potentiates
substance P- and capsaicin-induced bronchial smooth muscle contractions in humans. Am
Rev Respir Dis 1991;143:1416-18.
53. Sheldrick RLG, Rabe KF, Fischer A, Magnussen H, Coleman RA. Further evidence that
tachykinin-induced contraction of human isolated bronchus is mediated only by NK2
receptors. Neuropeptides 1995;29:281-92.
54. Honda I, Kohrogi H, Yamaguchi T, Hamamoto J, Hirata N, Iwagoe H, et al. Tachykinin
antagonist FK224 inhibits neurokinin A-, substance P- and capsaicin-induced human
bronchial contraction. Fundam Clin Pharmacol 1997;11:260-66.
55. Ellis JL, Sham JSK, Undem BJ. Tachykinin-independent effects of capsaicin on smooth
muscle in human isolated bronchi. Am J Respir Crit Care Med 1997;155:751-55.
56. Fuller RW, Dixon CMS, Barnes PJ. Bronchoconstrictor response to inhaled capsaicin in
man. J Appl Physiol 1985;58:1080-84.
57. Ireland SJ, Bailey F, Cook A, Hagan RM, Jordan CC, Stephens-Smith ML. Receptors
mediating tachykinin-induced contractile responses in guinea-pig trachea. Br J Pharmacol
1991;103:1463-69.
58. Boni P, Ballati L, Evangelista S. Tachykinin NK1 and NK2 receptors mediate the non-
cholinergic bronchospastic response to capsaicin and vagal stimulation in guinea-pigs.
J Auton Pharmacol 1995;15:49-54.
59. Martin CAE, Naline E, Emonds-Alt X, Advenier C. Influence of (/-)-CP-96,345 and
SR 48968 on electrical field stimulation of the isolated guinea-pig main bronchus. Eur J
Pharmacol 1992;224:137-43.
60. Joos GF, Kips JC, Pauwels RA.
In vivo
characterization of the tachykinin receptors
involved in the direct and indirect bronchoconstrictor effect of tachykinins in the rat. Am J
Respir Crit Care Med 1994;149:1160-66.
61. Joos GF, Lefebvre RA, Kips JC, Pauwels RA. Tachykinins contract trachea from
Fisher344 rats by interaction with a NK
1
receptor. Eur J Pharmacol 1994;271:47-54.
62. Advenier C, Naline E, Toty L, Bakdach H, Edmonds-Alt X, Vilain P, et al. Effects on the
isolated human bronchus of SR 48968, a potent and selective nonpeptide antagonist of the
neurokinin A (NK2) receptors. Am Rev Respir Dis 1992;146:1177-81.
63. Naline E, Molimard M, Regoli D, Emonds-Alt X, Bellamy JF, Advenier C. Evidence
for functional tachykinin NK1 receptors on human isolated small bronchi. Am J Physiol
1996;271:L763-67.
